FLG and metabolic syndrome: While the negative association between filaggrin mutation carrier status and metabolic syndrome reached borderline significance before Bonferroni adjustments, there were no statistically significant associations between filaggrin mutation carrier status and blood pressure (systolic or diastolic), BMI or waist circumference.